Teprotumumab per il trattamento dell’oftalmopatia basedowiana attiva
Crossref DOI link: https://doi.org/10.1007/s40619-020-00809-w
Published Online: 2020-11-10
Published Print: 2020-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Norello, Dario
Peri, Alessandro
Funding for this research was provided by:
UniversitĂ degli Studi di Firenze
Text and Data Mining valid from 2020-11-10
Version of Record valid from 2020-11-10
Article History
Accepted: 25 September 2020
First Online: 10 November 2020